8 December 2016 Introductory investigations of dermatologic diode laser with wavelengths 975 nm: clinical therapy of Recklinghausen disease and of hemangiomas
Author Affiliations +
Proceedings Volume 10159, Laser Technology 2016: Progress and Applications of Lasers; 101590H (2016) https://doi.org/10.1117/12.2263511
Event: XIth Symposium on Laser Technology, 2016, Jastarnia, Poland
Abstract
The newly developed pulsed/cw dermatological laser (with wavelengths 975 nm) is applied for therapies requiring deep penetration of tissue e.g. cutaneous (dermal) neurofibroma (Recklinghausen disease) or hemangiomas. As the selected eight patients had been treated previously using pulsed a Nd:YAG laser a comparison of these therapies was possible. The results of cutaneous neurofibroma therapy using diode laser show an improvement compared with the case of Ho:YAG and Nd:YAG laser therapies - however this should be checked for a larger number of patients.
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
J. Szymańczyk, W. Cenian, L. Piechowski, M. Sawczak, M. Jędrzejewska-Szczerska, A. Cenian, "Introductory investigations of dermatologic diode laser with wavelengths 975 nm: clinical therapy of Recklinghausen disease and of hemangiomas ", Proc. SPIE 10159, Laser Technology 2016: Progress and Applications of Lasers, 101590H (8 December 2016); doi: 10.1117/12.2263511; https://doi.org/10.1117/12.2263511
PROCEEDINGS
9 PAGES


SHARE
Back to Top